Results 171 to 180 of about 128,993 (222)

Observational study of trastuzumab biosimilar in patients with HER2-positive breast cancer under routine clinical practice conditions in Morocco. [PDF]

open access: yesBMC Cancer
Errihani H   +11 more
europepmc   +1 more source

Similarity assessment of disulfide isoform profiles between the romosozumab biosimilar and the reference medicinal product. [PDF]

open access: yesSci Rep
Zhao D   +11 more
europepmc   +1 more source

Evaluating the feasibility of health care databases for assessing the safety of switching between originator biologics and biosimilars. [PDF]

open access: yesJ Manag Care Spec Pharm
Mendelsohn AB   +5 more
europepmc   +1 more source

Can Biosimilar Products Be Interchangeable? Pharmaceutical Perspective in the Implementation of Biosimilars in Oncology

Journal of Oncology Pharmacy Practice, 2021
Objective To evaluate the safety in the interchangeability of biosimilar products approved for cancer treatment from a pharmaceutical perspective. Methods A literature review was carried out using the descriptors “Biosimilar ...
Iago Dillion Lima Cavalcanti   +1 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy